Structural characterization of the Man5 glycoform of human IgG3 Fc

Molecular Immunology

Volumn 92, Issue , 2017, Pages 28-37

  Shah, Ishan S ^a   Lovell, Scott ^a   Mehzabeen, Nurjahan ^a   Battaile, Kevin P ^b   Tolbert, Thomas J ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE   (United States)

Author keywords

Fc receptor; Glycosylation; High mannose; Immunoglobulin G; X ray crystal structure

Indexed keywords

ARGININE; FC RECEPTOR; HISTIDINE; IMMUNOGLOBULIN FC FRAGMENT; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G1; IMMUNOGLOBULIN G2; IMMUNOGLOBULIN G3; IMMUNOGLOBULIN G4; ISOLEUCINE; MANNOSE; N ACETYLGLUCOSAMINE; PROTEIN; PROTEIN A; PROTEIN G; RHEUMATOID FACTOR; TRIPARTITIE MOTIF 21; UNCLASSIFIED DRUG; GLYCOPROTEIN;

ANTIGEN ANTIBODY COMPLEX; ANTIGEN BINDING; ARTICLE; BINDING AFFINITY; COMPARATIVE STUDY; COMPLEMENT ACTIVATION; CONTROLLED STUDY; CRYSTAL STRUCTURE; GLYCOPROTEIN SYNTHESIS; GLYCOSYLATION; HUMAN; IMMUNOGLOBULIN STRUCTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN INTERACTION; SEQUENCE ANALYSIS; STRUCTURE ANALYSIS; CHEMISTRY; GENETICS; X RAY CRYSTALLOGRAPHY;

CRYSTALLOGRAPHY, X-RAY; GLYCOPROTEINS; GLYCOSYLATION; HUMANS; IMMUNOGLOBULIN FC FRAGMENTS; IMMUNOGLOBULIN G; MANNOSE;

EID: 85031012189     PISSN: 01615890     EISSN: 18729142     Source Type: Journal    
DOI: 10.1016/j.molimm.2017.10.001     Document Type: Article

References (63)

1. Adams, P.D., Afonine, P.V., Bunkoczi, G., Chen, V.B., Davis, I.W., Echols, N., Headd, J.J., Hung, L.W., Kapral, G.J., Grosse-Kunstleve, R.W., McCoy, A.J., Moriarty, N.W., Oeffner, R., Read, R.J., Richardson, D.C., Richardson, J.S., Terwilliger, T.C., Zwart, P.H., PHENIX: a comprehensive python-based system for macromolecular structure solution. Acta Crystallogr. D Biol. Crystallogr. 66 (2010), 213–221.
2. Akerström, B., Björck, L., A physicochemical study of protein G, a molecule with unique immunoglobulin G-binding properties. J. Biol. Chem. 261 (1986), 10240–10247.
3. Alessandri, L., Ouellette, D., Acquah, A., Rieser, M., LeBlond, D., Saltarelli, M., Radziejewski, C., Fujimori, T., Correia, I., Increased serum clearance of oligomannose species present on a human IgG1 molecule. MAbs 4 (2012), 509–520.
4. ®. 2001 http://www.imgt.org/IMGTScientificChart/Numbering/Hu_IGHGnber.html.
5. Borrok, M.J., Jung, S.T., Kang, T.H., Monzingo, A.F., Georgiou, G., Revisiting the role of glycosylation in the structure of human IgG Fc. ACS Chem. Biol. 7 (2012), 1596–1602.
6. ®. 2003 https://www.imgt.org/IMGTrepertoire/Proteins/taballeles/human/IGH/IGHC/Hu_IGHCall.html.
7. Bowden, T.A., Baruah, K., Coles, C.H., Harvey, D.J., Yu, X., Song, B.-D., Stuart, D.I., Aricescu, A.R., Scanlan, C.N., Jones, E.Y., Chemical and structural analysis of an antibody folding intermediate trapped during glycan biosynthesis. J. Am. Chem. Soc. 134 (2012), 17554–17563.
8. Brooks, S.A., Protein Glycosylation. 2010, John Wiley and Sons Inc, 1–25.
9. Bruhns, P., Iannascoli, B., England, P., Mancardi, D.A., Fernandez, N., Jorieux, S., Daëron, M., Specificity and affinity of human Fcγ receptors and their polymorphic variants for human IgG subclasses. Blood 113 (2009), 3716–3725.
10. Chen, V.B., Arendall, W.B. 3rd, Headd, J.J., Keedy, D.A., Immormino, R.M., Kapral, G.J., Murray, L.W., Richardson, J.S., Richardson, D.C., MolProbity: all-atom structure validation for macromolecular crystallography. Acta Crystallogr. D Biol. Crystallogr. 66 (2010), 12–21.
11. Choi, B.-K., Warburton, S., Lin, H., Patel, R., Boldogh, I., Meehl, M., d'Anjou, M., Pon, L., Stadheim, T.A., Sethuraman, N., Improvement of N-glycan site occupancy of therapeutic glycoproteins produced in Pichia pastoris. Appl. Microbiol. Biotechnol. 95 (2012), 671–682.
12. Chung, A.W., Ghebremichael, M., Robinson, H., Brown, E., Choi, I., Lane, S., Dugast, A.-S., Schoen, M.K., Rolland, M., Suscovich, T.J., Polyfunctional Fc-effector profiles mediated by IgG subclass selection distinguish RV144 and VAX003 vaccines. Sci. Trans. Med., 6, 2014 228ra238–228ra238.
13. Crispin, M., Bowden, T.A., Coles, C.H., Harlos, K., Aricescu, A.R., Harvey, D.J., Stuart, D.I., Jones, E.Y., Carbohydrate and domain architecture of an immature antibody glycoform exhibiting enhanced effector functions. J. Mol. Biol. 387 (2009), 1061–1066.
14. Cuskin, F., Lowe, E.C., Temple, M.J., Zhu, Y., Cameron, E.A., Pudlo, N.A., Porter, N.T., Urs, K., Thompson, A.J., Cartmell, A., Human gut Bacteroidetes can utilize yeast mannan through a selfish mechanism. Nature 517 (2015), 165–169.
15. Deisenhofer, J., Crystallographic refinement and atomic models of a human Fc fragment and its complex with fragment B of protein A from Staphylococcus aureus at 2.9-and 2.8-. ANG. resolution. Biochemistry 20 (1981), 2361–2370.
16. Diederichs, K., Karplus, P.A., Improved R-factors for diffraction data analysis in macromolecular crystallography. Nat. Struct. Biol. 4 (1997), 269–275.
17. Emsley, P., Lohkamp, B., Scott, W.G., Cowtan, K., Features and development of coot. Acta Crystallogr. D Biol. Crystallogr. 66 (2010), 486–501.
18. Evans, P., Scaling and assessment of data quality. Acta Crystallogr. D Biol. Crystallogr. 62 (2006), 72–82.
19. Evans, P.R., An introduction to data reduction: space-group determination, scaling and intensity statistics. Acta Crystallogr. D Biol. Crystallogr. 67 (2011), 282–292.
20. Evans, P., Biochemistry. Resolving some old problems in protein crystallography. Science 336 (2012), 986–987.
21. Flynn, G.C., Chen, X., Liu, Y.D., Shah, B., Zhang, Z., Naturally occurring glycan forms of human immunoglobulins G1 and G2. Mol. Immunol. 47 (2010), 2074–2082.
22. Giuntini, S., Granoff, D., Beernink, P., Ihle, O., Bratlie, D., Michaelsen, T., Human IgG1, IgG3, and IgG3 hinge-truncated mutants show different protection capabilities against meningococci depending on the target antigen and epitope specificity. Clin. Vaccine Immunol. 23 (2016), 698–706.
23. Goetze, A.M., Liu, Y.D., Zhang, Z., Shah, B., Lee, E., Bondarenko, P.V., Flynn, G.C., High-mannose glycans on the Fc region of therapeutic IgG antibodies increase serum clearance in humans. Glycobiology 21 (2011), 949–959.
24. Hopkins, D., Gomathinayagam, S., Rittenhour, A.M., Du, M., Hoyt, E., Karaveg, K., Mitchell, T., Nett, J.H., Sharkey, N.J., Stadheim, T.A., Elimination of β-mannose glycan structures in Pichia pastoris. Glycobiology 21 (2011), 1616–1626.
25. Huang, X., Zheng, F., Zhan, C.-G., Binding structures and energies of the human neonatal Fc receptor with human Fc and its mutants by molecular modeling and dynamics simulations. Mol. Biosyst. 9 (2013), 3047–3058.
26. Idusogie, E.E., Presta, L.G., Gazzano-Santoro, H., Totpal, K., Wong, P.Y., Ultsch, M., Meng, Y.G., Mulkerrin, M.G., Mapping of the C1q binding site on rituxan, a chimeric antibody with a human IgG1 Fc. J. Immunol. 164 (2000), 4178–4184.
27. Jefferis, R., Lefranc, M.P., Human immunoglobulin allotypes: possible implications for immunogenicity. MAbs 1 (2009), 332–338.
28. Kabsch, W., Automatic indexing of rotation diffraction patterns. J. Appl. Crystallogr. 21 (1988), 67–72.
29. Kabsch, W., Xds. Acta Crystallogr. D Biol. Crystallogr. 66 (2010), 125–132.
30. Karplus, P.A., Diederichs, K., Linking crystallographic model and data quality. Science 336 (2012), 1030–1033.
31. Krapp, S., Mimura, Y., Jefferis, R., Huber, R., Sondermann, P., Structural analysis of human IgG-Fc glycoforms reveals a correlation between glycosylation and structural integrity. J. Mol. Biol. 325 (2003), 979–989.
32. Kuby, J., Immunology. 3rd ed., 1997, W.H Freeman, New York.
33. Langer, G., Cohen, S.X., Lamzin, V.S., Perrakis, A., Automated macromolecular model building for X-ray crystallography using ARP/wARP version 7. Nat. Protoc. 3 (2008), 1171–1179.
34. Lefranc, M.-P., Lefranc, G., Human Gm, Km, and Am allotypes and their molecular characterization: a remarkable demonstration of polymorphism. Methods Mol. Biol. 882 (2012), 635–680.
35. Loghem, E.v., Frangione, B., Recht, B., Franklin, E., Staphylococcal protein A and human IgG subclasses and allotypes. Scand. J. Immunol. 15 (1982), 275–278.
36. Martin, W.L., West, A.P. Jr, Gan, L., Bjorkman, P.J., Crystal structure at 2.8 Å of an FcRn/heterodimeric Fc complex: mechanism of pH-dependent binding. Mol. Cell 7 (2001), 867–877.
37. McCoy, A.J., Grosse-Kunstleve, R.W., Adams, P.D., Winn, M.D., Storoni, L.C., Read, R.J., Phaser crystallographic software. J. Appl. Cryst. 40 (2007), 658–674.
38. Michaelsen, T.E., Frangione, B., Franklin, E.C., Primary structure of the hinge region of human IgG3. Probable quadruplication of a 15-amino acid residue basic unit. J. Biol. Chem. 252 (1977), 883–889.
39. Morell, A., Terry, W.D., Waldmann, T.A., Metabolic properties of IgG subclasses in man. J. Clin. Invest., 49, 1970, 673.
40. Nagae, M., Yamaguchi, Y., Function and 3D structure of the N-glycans on glycoproteins. Int. J. Mol. Sci. 13 (2012), 8398–8429.
41. Oganesyan, V., Damschroder, M.M., Cook, K.E., Li, Q., Gao, C., Wu, H., Dall'Acqua, W.F., Structural insights into neonatal Fc receptor-based recycling mechanisms. J. Biol. Chem. 289 (2014), 7812–7824.
42. Okbazghi, S.Z., More, A.S., White, D.R., Duan, S., Shah, I.S., Joshi, S.B., Middaugh, C.R., Volkin, D.B., Tolbert, T.J., Production, characterization, and biological evaluation of well-defined IgG1 Fc glycoforms as a model system for biosimilarity analysis. J. Pharm. Sci. 105 (2016), 559–574.
43. Potterton, L., McNicholas, S., Krissinel, E., Gruber, J., Cowtan, K., Emsley, P., Murshudov, G.N., Cohen, S., Perrakis, A., Noble, M., Developments in the CCP4 molecular-graphics project. Acta Crystallogr. D Biol. Crystallogr. 60 (2004), 2288–2294.
44. Reusch, D., Tejada, M.L., Fc glycans of therapeutic antibodies as critical quality attributes. Glycobiology 25 (2015), 1325–1334.
45. Roopenian, D.C., Akilesh, S., FcRn: the neonatal Fc receptor comes of age. Nat. Rev. Immunol. 7 (2007), 715–725.
46. Roux, K.H., Strelets, L., Michaelsen, T.E., Flexibility of human IgG subclasses. J. Immunol. 159 (1997), 3372–3382.
47. Sauer-Eriksson, A.E., Kleywegt, G.J., Uhlén, M., Jones, T.A., Crystal structure of the C2 fragment of streptococcal protein G in complex with the Fc domain of human IgG. Structure 3 (1995), 265–278.
48. Shields, R.L., Namenuk, A.K., Hong, K., Meng, Y.G., Rae, J., Briggs, J., Xie, D., Lai, J., Stadlen, A., Li, B., High resolution mapping of the binding site on human IgG1 for FcγRI, FcγRII, FcγRIII, and FcRn and design of IgG1 variants with improved binding to the FcγR. J. Biol. Chem. 276 (2001), 6591–6604.
49. Stapleton, N.M., Andersen, J.T., Stemerding, A.M., Bjarnarson, S.P., Verheul, R.C., Gerritsen, J., Zhao, Y., Kleijer, M., Sandlie, I., de Haas, M., Competition for FcRn-mediated transport gives rise to short half-life of human IgG3 and offers therapeutic potential. Nat. Commun., 2, 2011, 599.
50. Strop, P., Ho, W.-H., Boustany, L.M., Abdiche, Y.N., Lindquist, K.C., Farias, S.E., Rickert, M., Appah, C.T., Pascua, E., Radcliffe, T., Generating bispecific human IgG1 and IgG2 antibodies from any antibody pair. J. Mol. Biol. 420 (2012), 204–219.
51. Subedi, G.P., Hanson, Q.M., Barb, A.W., Restricted motion of the conserved immunoglobulin G1 N-glycan is essential for efficient FcγRIIIa binding. Structure 22 (2014), 1478–1488.
52. Tao, M.H., Morrison, S.L., Studies of aglycosylated chimeric mouse-human IgG: role of carbohydrate in the structure and effector functions mediated by the human IgG constant region. J. Immunol. 143 (1989), 2595–2601.
53. Tao, M.-H., Smith, R., Morrison, S., Structural features of human immunoglobulin G that determine isotype-specific differences in complement activation. J. Exp. Med. 178 (1993), 661–667.
54. Teplyakov, A., Zhao, Y., Malia, T.J., Obmolova, G., Gilliland, G.L., IgG2 Fc structure and the dynamic features of the IgG CH2–CH3 interface. Mol. Immunol. 56 (2013), 131–139.
55. Thommesen, J.E., Michaelsen, T.E., Løset, G.Å., Sandlie, I., Brekke, O.H., Lysine 322 in the human IgG3CH2 domain is crucial for antibody dependent complement activation. Mol. Immunol. 37 (2000), 995–1004.
56. Vidarsson, G., Dekkers, G., Rispens, T., IgG subclasses and allotypes: from structure to effector functions. Front. Immunol., 5, 2014, 520.
57. Vonrhein, C., Flensburg, C., Keller, P., Sharff, A., Smart, O., Paciorek, W., Womack, T., Bricogne, G., Data processing and analysis with the auto PROC toolbox. Acta Crystallogr. D Biol. Crystallogr. 67 (2011), 293–302.
58. Walker, M.R., Lund, J., Thompson, K.M., Jefferis, R., Aglycosylation of human IgG1 and IgG3 monoclonal antibodies can eliminate recognition by human cells expressing Fc gamma RI and/or Fc gamma RII receptors. Biochem. J., 259, 1989, 347.
59. Weerawarna, P.M., Kim, Y., Galasiti Kankanamalage, A.C., Damalanka, V.C., Lushington, G.H., Alliston, K.R., Mehzabeen, N., Battaile, K.P., Lovell, S., Chang, K.O., Groutas, W.C., Structure-based design and synthesis of triazole-based macrocyclic inhibitors of norovirus protease: structural, biochemical, spectroscopic, and antiviral studies. Eur. J. Med. Chem. 119 (2016), 300–318.
60. Weiss, M.S., Global indicators of X-ray data quality. J. Appl. Crystallogr. 34 (2001), 130–135.
61. Wuhrer, M., Stam, J.C., van de Geijn, F.E., Koeleman, C.A., Verrips, C.T., Dolhain, R.J., Hokke, C.H., Deelder, A.M., Glycosylation profiling of immunoglobulin G (IgG) subclasses from human serum. Proteomics 7 (2007), 4070–4081.
62. Xiao, J., Chen, R., Pawlicki, M.A., Tolbert, T.J., Targeting a homogeneously glycosylated antibody Fc to bind cancer cells using a synthetic receptor ligand. J. Am. Chem. Soc. 131 (2009), 13616–13618.
63. Yu, M., Brown, D., Reed, C., Chung, S., Lutman, J., Stefanich, E., Wong, A., Stephan, J.-P., Bayer, R., Production, characterization and pharmacokinetic properties of antibodies with N-linked mannose-5 glycans. MAbs 4 (2012), 475–487.